🇧🇪 Belgium Country × Condition
amyotrophic lateral sclerosis Clinical Trials in Belgium
Active clinical trials for amyotrophic lateral sclerosis with research sites in Belgium. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇧🇪 Belgium
Active Trials in Belgium (3)
NCT03127267 Phase 3
Recruiting
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Enrollment
495 pts
Country
🇧🇪 Belgium
AB Science
View Trial → NCT04882904
Recruiting
Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
Enrollment
45 pts
Country
🇧🇪 Belgium
Centre Hospitalier Universitaire de...
View Trial → NCT06228001
Recruiting
Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.
Enrollment
30 pts
Country
🇧🇪 Belgium
Centre Hospitalier Universitaire de...
View Trial → Frequently Asked Questions
How many amyotrophic lateral sclerosis clinical trials are active in Belgium?
There are currently 3 active clinical trials for amyotrophic lateral sclerosis with sites in Belgium, of which 3 are actively recruiting patients.
How can I join a amyotrophic lateral sclerosis clinical trial in Belgium?
To join a amyotrophic lateral sclerosis clinical trial in Belgium, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Belgium directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are amyotrophic lateral sclerosis trials in Belgium?
Active amyotrophic lateral sclerosis trials in Belgium span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology